258 related articles for article (PubMed ID: 28934110)
1. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
Julik E; Reyes-Del Valle J
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
[TBL] [Abstract][Full Text] [Related]
2. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
3. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
4. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
6. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
7. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
8. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
[TBL] [Abstract][Full Text] [Related]
9. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
[TBL] [Abstract][Full Text] [Related]
10. The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles.
Lobanova LM; Eng NF; Satkunarajah M; Mutwiri GK; Rini JM; Zakhartchouk AN
Vaccine; 2012 Apr; 30(20):3061-7. PubMed ID: 22406109
[TBL] [Abstract][Full Text] [Related]
11. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
13. Mucosal adenovirus-vectored vaccine for measles.
Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
[TBL] [Abstract][Full Text] [Related]
14. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
[TBL] [Abstract][Full Text] [Related]
15. Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein.
Kumada A; Komase K; Nakayama T
Vaccine; 2004 Jan; 22(3-4):309-16. PubMed ID: 14670311
[TBL] [Abstract][Full Text] [Related]
16. C3d enhancement of neutralizing antibodies to measles hemagglutinin.
Green TD; Newton BR; Rota PA; Xu Y; Robinson HL; Ross TM
Vaccine; 2001 Oct; 20(1-2):242-8. PubMed ID: 11567770
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.
Qi Y; Xing K; Zhang L; Zhao F; Yao M; Hu A; Wu X
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1945-1957. PubMed ID: 30090962
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
[TBL] [Abstract][Full Text] [Related]
20. An immune competent mouse model for the characterization of recombinant measles vaccines.
Marty RR; Knuchel MC; Morin TN; Naim HY
Hum Vaccin Immunother; 2015; 11(1):83-90. PubMed ID: 25483519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
